Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

First Experience Using 18F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma

Lukas Kessler, Anna M. Schlitter, Markus Krönke, Alexander von Werder, Robert Tauber, Tobias Maurer, Simon Robinson, Cesare Orlandi, Michael Herz, Behrooz H. Yousefi, Stephan G. Nekolla, Markus Schwaiger, Matthias Eiber and Christoph Rischpler
Journal of Nuclear Medicine April 2021, 62 (4) 479-485; DOI: https://doi.org/10.2967/jnumed.120.248021
Lukas Kessler
1Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna M. Schlitter
2Institute of Pathology, Technical University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Krönke
3Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander von Werder
4Department of Gastroenterology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Tauber
5Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Maurer
5Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Robinson
6Discovery Research, Lantheus Medical Imaging, North Billerica, Massachusetts; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cesare Orlandi
6Discovery Research, Lantheus Medical Imaging, North Billerica, Massachusetts; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Herz
3Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Behrooz H. Yousefi
3Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
7Department of Nuclear Medicine, Philipps University of Marburg, Marburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan G. Nekolla
3Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schwaiger
3Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Eiber
3Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Rischpler
1Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
3Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 62 no. 4 479-485
DOI 
https://doi.org/10.2967/jnumed.120.248021
PubMed 
32859709

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication April 27, 2020
  • Accepted for publication July 20, 2020
  • Published online March 29, 2021.

Article Versions

  • previous version (August 28, 2020 - 14:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Lukas Kessler1,
  2. Anna M. Schlitter2,
  3. Markus Krönke3,
  4. Alexander von Werder4,
  5. Robert Tauber5,
  6. Tobias Maurer5,
  7. Simon Robinson6,
  8. Cesare Orlandi6,
  9. Michael Herz3,
  10. Behrooz H. Yousefi3,7,
  11. Stephan G. Nekolla3,
  12. Markus Schwaiger3,
  13. Matthias Eiber*,3 and
  14. Christoph Rischpler*,1,3
  1. 1Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  2. 2Institute of Pathology, Technical University Munich, Munich, Germany
  3. 3Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  4. 4Department of Gastroenterology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  5. 5Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  6. 6Discovery Research, Lantheus Medical Imaging, North Billerica, Massachusetts; and
  7. 7Department of Nuclear Medicine, Philipps University of Marburg, Marburg, Germany
  1. For correspondence or reprints contact: Christoph Rischpler, Klinikum rechts der Isar, Nuklearmedizinische Klinik und Poliklinik, Ismaninger Strasse 22, 81675 München, Germany. E-mail: c.rischpler{at}tum.de
  1. ↵* Contributed equally to this work.

View Full Text

Statistics from Altmetric.com

Cited By...

  • 6 Citations
  • 6 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Diagnostic Performance of124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
    Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger, Wolfgang P. Fendler
    Journal of Nuclear Medicine 2022 63 6
  • Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment
    Hermine Mohr, Alessia Foscarini, Katja Steiger, Simone Ballke, Christoph Rischpler, Franz Schilling, Natalia S. Pellegata
    EJNMMI Research 2021 11 1
  • Optimal and novel imaging of the adrenal glands
    Patrick J. Navin, Michael R. Moynagh
    Current Opinion in Endocrinology, Diabetes & Obesity 2022 29 3
  • Adrenal functional imaging – which marker for which indication?
    Rudolf A. Werner, Philipp E. Hartrampf, Andreas Schirbel, Stefanie Hahner
    Current Opinion in Urology 2022 32 6
  • Norepinephrine Transporter–Targeted Cancer Theranostics—New Horizons
    Takahiro Higuchi, Konrad Klimek, Daniel Groener, Xinyu Chen, Rudolf A. Werner
    Clinical Nuclear Medicine 2024
  • Hybrid imaging of neuroendocrine tumors in the heart: Union is strength
    Maria E. Marketou, Nikolaos Kapsoritakis, Olga Bourogianni, Alexandros Patrianakos, George Kochiadakis, Anthoula Plevritaki, Sophia Papadaki, Stelios Zervakis, Fragiskos Parthenakis, Sophia Koukouraki
    Journal of Nuclear Cardiology 2023 30 1

Article usage

Article usage: August 2020 to April 2025

AbstractFullPdf
Aug 2020178018
Sep 2020273032
Oct 202013604
Nov 202012408
Dec 2020111011
Jan 20219505
Feb 202110504
Mar 20214181769
Apr 20218846265
May 20214012737
Jun 20211471218
Jul 2021126614
Aug 2021100813
Sep 202191511
Oct 2021334150
Nov 2021493856
Dec 2021494527
Jan 2022354227
Feb 202238449
Mar 2022427531
Apr 2022316733
May 2022215735
Jun 2022268335
Jul 2022235220
Aug 2022206510
Sep 2022223012
Oct 202263421
Nov 2022113616
Dec 2022133612
Jan 202383612
Feb 2023102715
Mar 2023175913
Apr 2023121511
May 2023181411
Jun 2023243213
Jul 2023193413
Aug 2023232914
Sep 2023222613
Oct 2023152312
Nov 2023193114
Dec 202394112
Jan 2024186517
Feb 202474217
Mar 2024123241
Apr 2024116828
May 2024293916
Jun 2024213413
Jul 2024272723
Aug 2024103226
Sep 202472921
Oct 2024152915
Nov 202411318
Dec 202452517
Jan 202523215
Feb 20251810124
Mar 2025138019
Apr 202564133
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (4)
Journal of Nuclear Medicine
Vol. 62, Issue 4
April 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First Experience Using 18F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
First Experience Using 18F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma
Lukas Kessler, Anna M. Schlitter, Markus Krönke, Alexander von Werder, Robert Tauber, Tobias Maurer, Simon Robinson, Cesare Orlandi, Michael Herz, Behrooz H. Yousefi, Stephan G. Nekolla, Markus Schwaiger, Matthias Eiber, Christoph Rischpler
Journal of Nuclear Medicine Apr 2021, 62 (4) 479-485; DOI: 10.2967/jnumed.120.248021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
First Experience Using 18F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma
Lukas Kessler, Anna M. Schlitter, Markus Krönke, Alexander von Werder, Robert Tauber, Tobias Maurer, Simon Robinson, Cesare Orlandi, Michael Herz, Behrooz H. Yousefi, Stephan G. Nekolla, Markus Schwaiger, Matthias Eiber, Christoph Rischpler
Journal of Nuclear Medicine Apr 2021, 62 (4) 479-485; DOI: 10.2967/jnumed.120.248021
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
  • Google Scholar

More in this TOC Section

Oncology

  • Radioimmunotherapy in Oncology
  • The Role of NAC FDG-PET/CT in Detecting Cutaneous Lesions
  • Quantitative assessment of radiation therapy-induced cardiovascular complications with FDG-PET and NaF-PET imaging in lung cancer and other thoracic malignancies
Show more Oncology

Translational

  • [99mTc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study
  • Imaging Diverse Pathogenic Bacteria In Vivo with 18F-Fluoromannitol PET
  • Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy
Show more Translational

Similar Articles

Keywords

  • PET/CT
  • PET/MRI
  • F-18 flubrobenguane
  • PET
  • paraganglioma
  • pheochromocytoma
SNMMI

© 2025 SNMMI

Powered by HighWire